Ivermectin Pill

DRUG4 trials

Sponsors

Stanford University, Mahidol University, Temple University, Barcelona Institute for Global Health

Conditions

Asymptomatic InfectionsAtopic DermatitisCovid19MalariaSARS-CoV2 Infection

Phase 2

Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis

WithdrawnNCT03553615

Stanford UniversityAtopic Dermatitis

Start: 2030-12-01End: 2030-12-31Updated: 2024-12-02

Phase 3

Outpatient Use of Ivermectin in COVID-19

WithdrawnNCT04530474

Temple UniversityCovid19

Start: 2021-04-01End: 2021-06-30Updated: 2021-05-26

Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA)

CompletedNCT04966702

Barcelona Institute for Global HealthMalaria

Start: 2022-03-17End: 2024-10-03Updated: 2025-03-14

Phase 4

Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection

Mahidol UniversityAsymptomatic Infections, SARS-CoV2 Infection

Start: 2020-07-13End: 2021-11-30Target: 80Updated: 2021-01-11

Related Papers

Direct and indirect protection against scabies through ivermectin mass drug administration designed for malaria in Mozambique: a substudy nested within a cluster-randomised, controlled trial.

2025-11-20

Ivermectin to reduce malaria transmission- safety and efficacy results from the BOHEMIA cluster randomized trial in Mozambique.

2025-11-07

Ivermectin to Control Malaria - A Cluster-Randomized Trial

Open Access CRIS of the University of Bern2025-07-24

Ivermectin to Control Malaria — A Cluster-Randomized Trial

New England Journal of Medicine2025-07-2313 citations

Collateral benefits of ivermectin mass drug administration designed for malaria against headlice in Mopeia, Mozambique: a cluster randomised controlled trial.

2025-03-271 citations

BOHEMIA a cluster randomized trial to assess the impact of an endectocide-based one health approach to malaria in Mozambique: baseline demographics and key malaria indicators.

2023-06-0410 citations

BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa-a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings.

2023-02-2127 citations